This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cov-2 | 743 |
immune | response | 119 |
covid-19 | patients | 114 |
respiratory | syndrome | 109 |
immune | system | 100 |
novel | coronavirus | 97 |
endothelial | cells | 70 |
covid-19 | infection | 66 |
inflammatory | cytokines | 60 |
immune | cells | 58 |
viral | infection | 46 |
inflammatory | response | 45 |
immune | responses | 43 |
viral | infections | 41 |
acute | lung | 40 |
- | cell | 32 |
endothelial | cell | 31 |
- | risk | 28 |
inflammatory | cytokine | 28 |
important | role | 26 |
severe | cases | 26 |
new | coronavirus | 24 |
inflammatory | responses | 22 |
human | coronavirus | 20 |
high | risk | 18 |
severe | covid-19 | 18 |
severe | disease | 18 |
- | protein | 17 |
high | levels | 17 |
pulmonary | disease | 16 |
respiratory | system | 15 |
respiratory | infections | 14 |
respiratory | disease | 13 |
respiratory | diseases | 13 |
covid-19 | cases | 13 |
inflammatory | effects | 13 |
- | drug | 12 |
clinical | studies | 12 |
key | role | 12 |
several | studies | 12 |
severe | sars | 12 |
higher | levels | 11 |
higher | risk | 11 |
inflammatory | effect | 9 |
human | ace2 | 9 |
new | cases | 8 |
potential | role | 8 |
pulmonary | system | 8 |
covid-19 | infections | 8 |
high | level | 7 |
inflammatory | cells | 7 |
respiratory | infection | 7 |
respiratory | virus | 7 |
severe | lung | 7 |
immune | cell | 6 |
pulmonary | inflammation | 6 |
viral | protein | 6 |
therapeutic | effects | 6 |
therapeutic | effect | 6 |
- | coronavirus | 6 |
new | drugs | 6 |
human | cells | 6 |
covid-19 | patient | 6 |
several | factors | 5 |
such | effect | 5 |
human | lung | 5 |
vascular | cells | 5 |
viral | diseases | 5 |
novel | drug | 5 |
other | studies | 5 |
clinical | study | 5 |
new | virus | 5 |
lower | level | 5 |
innate | response | 5 |
inflammatory | drugs | 5 |
higher | level | 5 |
early | treatment | 5 |
severe | patients | 4 |
novel | treatment | 4 |
possible | role | 4 |
pulmonary | response | 4 |
respiratory | viruses | 4 |
low | vitamin | 4 |
therapeutic | role | 4 |
vascular | disease | 4 |
viral | activity | 4 |
viral | proteins | 4 |
lower | levels | 4 |
- | effects | 4 |
inflammatory | lung | 4 |
important | risk | 4 |
different | cell | 4 |
covid-19 | treatment | 4 |
covid-19 | disease | 4 |
- | treatment | 4 |
- | sars | 4 |
- | response | 4 |
- | infection | 4 |
inflammatory | diseases | 4 |
potential | drugs | 3 |
lower | risk | 3 |
novel | sars | 3 |
other | cytokines | 3 |
other | factors | 3 |
other | viruses | 3 |
therapeutic | drug | 3 |
respiratory | coronavirus | 3 |
respiratory | treatments | 3 |
specific | effects | 3 |
inflammatory | disease | 3 |
viral | effect | 3 |
inflammatory | factors | 3 |
pulmonary | diseases | 3 |
inflammatory | activity | 3 |
different | studies | 3 |
immune | systems | 3 |
- | cytokine | 3 |
- | level | 3 |
- | lung | 3 |
- | receptor | 3 |
- | cells | 3 |
different | viruses | 3 |
immune | effects | 3 |
endothelial | inflammation | 3 |
endothelial | protein | 3 |
high | ace2 | 3 |
early | disease | 3 |
several | drugs | 2 |
several | diseases | 2 |
several | disease | 2 |
respiratory | effects | 2 |
respiratory | cells | 2 |
potential | effects | 2 |
pulmonary | levels | 2 |
potential | treatment | 2 |
potential | effect | 2 |
other | infections | 2 |
potential | covid-19 | 2 |
severe | coronavirus | 2 |
several | viruses | 2 |
such | studies | 2 |
severe | infections | 2 |
severe | inflammations | 2 |
specific | cytokine | 2 |
specific | protein | 2 |
such | cases | 2 |
such | patients | 2 |
such | treatment | 2 |
therapeutic | treatment | 2 |
vascular | diseases | 2 |
vascular | inflammation | 2 |
vascular | risk | 2 |
viral | effects | 2 |
other | sars | 2 |
new | disease | 2 |
other | coronavirus | 2 |
human | infection | 2 |
other | cells | 2 |
- | disease | 2 |
- | factor | 2 |
- | syndrome | 2 |
acute | coronavirus | 2 |
clinical | disease | 2 |
clinical | treatment | 2 |
covid-19 | risk | 2 |
different | cells | 2 |
high | infection | 2 |
human | cell | 2 |
clinical | effects | 2 |
human | lungs | 2 |
key | factor | 2 |
immune | activity | 2 |
lowest | risk | 2 |
lowest | levels | 2 |
low | risk | 2 |
key | factors | 2 |
low | levels | 2 |
innate | responses | 2 |
inflammatory | cell | 2 |
important | roles | 2 |
important | factors | 2 |
other | treatment | 1 |
potential | factors | 1 |
other | vitamin | 1 |
possible | infection | 1 |
possible | sars | 1 |
potential | ace2 | 1 |
pulmonary | drug | 1 |
potential | level | 1 |
potential | receptors | 1 |
potential | risks | 1 |
pulmonary | ace2 | 1 |
pulmonary | infection | 1 |
other | drug | 1 |
other | inflammation | 1 |
low | inflammation | 1 |
other | activities | 1 |
novel | virus | 1 |
novel | disease | 1 |
novel | cytokine | 1 |
new | viruses | 1 |
new | treatment | 1 |
new | drug | 1 |
new | covid-19 | 1 |
lower | covid-19 | 1 |
lower | case | 1 |
low | level | 1 |
pulmonary | syndrome | 1 |
low | cells | 1 |
pulmonary | infections | 1 |
such | activity | 1 |
pulmonary | virus | 1 |
respiratory | systems | 1 |
viral | systems | 1 |
viral | receptors | 1 |
viral | receptor | 1 |
viral | drugs | 1 |
viral | drug | 1 |
vascular | system | 1 |
vascular | proteins | 1 |
vascular | effects | 1 |
therapeutic | treatments | 1 |
therapeutic | protein | 1 |
therapeutic | levels | 1 |
such | treatments | 1 |
such | study | 1 |
such | sars | 1 |
such | protein | 1 |
such | factors | 1 |
such | disease | 1 |
key | cytokines | 1 |
specific | sars | 1 |
specific | factors | 1 |
specific | drugs | 1 |
specific | case | 1 |
severe | response | 1 |
severe | infection | 1 |
several | sars | 1 |
several | coronavirus | 1 |
several | cell | 1 |
key | studies | 1 |
human | receptor | 1 |
innate | cytokine | 1 |
inflammatory | role | 1 |
earlier | study | 1 |
earlier | studies | 1 |
different | treatments | 1 |
different | sars | 1 |
different | responses | 1 |
different | drug | 1 |
different | cytokines | 1 |
covid-19 | virus | 1 |
covid-19 | lungs | 1 |
covid-19 | cytokine | 1 |
clinical | syndrome | 1 |
clinical | sars | 1 |
clinical | levels | 1 |
clinical | effect | 1 |
clinical | cases | 1 |
clinical | case | 1 |
acute | inflammation | 1 |
acute | effects | 1 |
acute | covid-19 | 1 |
- | vitamin | 1 |
- | virus | 1 |
- | proteins | 1 |
- | inflammation | 1 |
- | factors | 1 |
- | cytokines | 1 |
- | activity | 1 |
- | ace2 | 1 |
earliest | drugs | 1 |
early | cases | 1 |
early | lung | 1 |
human | infections | 1 |
inflammatory | protein | 1 |
inflammatory | activities | 1 |
important | system | 1 |
important | lung | 1 |
important | factor | 1 |
important | cytokine | 1 |
important | cell | 1 |
immune | effect | 1 |
humans | effects | 1 |
human | sars | 1 |
human | proteins | 1 |
human | protein | 1 |
human | diseases | 1 |
early | response | 1 |
human | cases | 1 |
highest | risk | 1 |
highest | levels | 1 |
higher | inflammation | 1 |
higher | infection | 1 |
higher | case | 1 |
higher | activity | 1 |
high | virus | 1 |
high | sars | 1 |
high | disease | 1 |
high | cytokine | 1 |
high | activity | 1 |
viral | treatments | 1 |